As a leading biotech products development and manufacturing company, Mufeng provides gene, protein, antibody, ELISA kit, and other relevant raw materials for the medical and healthcare market. At the same time, the company consolidates its available resources and manufactures various nonwovens products including disposable face masks, mop caps, bouffant caps, coveralls, surgical gowns, lab coats, under pads, sleeves and shoe covers. Together these products generate about 30% of company revenue each year. Mufeng is equipped with first-class cleanrooms and other advanced equipment. In addition, the company’s products meet the international CE, ISO, FDA certifications.
The company says entering into the global market has brought a lot of business opportunities for Mufeng, as it is able to establish a direct connection with customers worldwide. Today, the company provides a broad range of high quality nonwoven products with competitive prices, which helps Mufeng establish its position in the nonwovens market. Every month, the company exports about 60-80 units of 40” GPs to the U.S., Middle East, Indian and European markets.
As raw materials and other operational costs continue to rise, together with fierce competition in the market and a slow down in the economy, the company is facing critical challenges. However, the company says it is striving to improve its competitiveness through new product development, product portfolio expansion and, at the same time, with measures to improve productivity, increase revenues, create value-added products, rationalize production processes, reduce costs and expand its footprint with new offices and other investments.
For Mufeng, facemask and coverall sales grew rapidly in 2013, as the market’s interest in these kinds of products continues to increase. In the future, the company is targeting further expansion of its international market presence and says it hopes to achieve 30% revenue growth for its nonwovens product business. n